VINC
Vincerx Pharma, Inc.
Set alert
0.01 USD 0.00 0.00%
0.0053 Day range 0.0053
0.001 52-week range 0.026
- YTD
- 0.00%
- 1 year
- -75.00%
- Open
- 0.0053
- Prev close
- 0.013
- Mkt cap
- 68.05K
- Vol
- 22
- Avg vol
- 2.16K
- EPS
- -9.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0053
- High
- 0.0053
- Forward P/E
- -0.30
- Beta
- 0.00
- Short ratio
- 2.22
- Inst. own
- 24.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 0.29914
- 200-d avg
- 1.16
- 1y target
- 6.00
Financial health
Altman Z-Score
-76.48 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.9×
FY 2019 5y median -3.5× FY 2024
P/S 0.0×
FY 2019 5y median 0.0× FY 2024
P/B 10.1×
FY 2019 5y median 10.1× FY 2024
P/FCF -1.1×
FY 2019 5y median -3.4× FY 2024
EV/EBITDA -0.7×
FY 2019 5y median -3.3× FY 2024
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2024
FCF Yield -94.9%
FY 2019 5y median -29.2% FY 2024
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2024
ROE -1104.0%
FY 2019 5y median -137.1% FY 2024
ROIC -1155.0%
FY 2019 5y median -134.3% FY 2024
ROA -375.7%
FY 2019 5y median -110.3% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2024
Operating Income 26.2%
FY 2019 FY 2024
EPS (diluted) 15.9%
FY 2019 FY 2024
Free Cash Flow 35.4%
FY 2019 FY 2024
Financial Health
Current Ratio 1.2×
FY 2019 5y median 2.6× FY 2024
Quick Ratio 1.2×
FY 2019 5y median 2.6× FY 2024
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2024
Net Debt / EBITDA 0.2×
FY 2019 5y median 0.3× FY 2024
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31